Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Basilea Pharmaceutica

Biotech & Life Sciences · Allschwil, Switzerland · Founded 2000 · IPO 2004 Thoroughbred

Commercial stage biopharmaceutical company

Valuation
$547M
Market cap · May/2026
Revenue
$213M
Latest reported FY
EBITDA
$59M
Latest reported FY

Global footprint

Where Basilea Pharmaceutica has talent and traffic

Workforce by country
13 countries with
team presence
🇨🇭 Switzerland80.9%
🇫🇷 France7.9%
🇩🇪 Germany2.4%
🇨🇳 China2.3%
🇦🇺 Australia0.8%
Top 5 of 13 shown
Web traffic by country
9.1K monthly visits
across markets
🇨🇭 Switzerland27.5%
🇺🇸 United States27.5%
🇩🇪 Germany17.6%
🇬🇧 United Kingdom14.3%
🇫🇷 France14.3%
Top 5 markets shown

Market sentiment

What the market is saying about Basilea Pharmaceutica

An AI-synthesized read of the highest-engagement posts about Basilea Pharmaceutica on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Basilea Pharmaceutica on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.